Safety and immunogenicity of adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine following blood and marrow transplantation in adults

Trial Profile

Safety and immunogenicity of adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine following blood and marrow transplantation in adults

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2007

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top